OR WAIT 15 SECS
UBM
Adeline Siew is editor for Pharmaceutical Technology Europe. She is also science editor for Pharmaceutical Technology.
October 02, 2018
Lipid-based formulations offer a means of addressing the physicochemical and biological challenges of poorly soluble APIs.
September 02, 2018
Senomyx uses an approach, known as taste-blocking, to address the challenges of bitter APIs. Kenneth J. Simone, vice-president of Pharmaceutical Business Development, Senomyx, speaks with Pharmaceutical Technology about this technology.
The level of tastemasking required will depend on the API properties and the dosage form design.
September 01, 2018
Immobilizing the antibodies on a solid-phase support, such as a resin, and carrying out the conjugation of the payload-linker while the antibodies are bound to that support will prevent aggregation at its source.